Alpha B-crystallin as a therapy for ischemia or inflammation
AssigneesThe Board of Trustees of the Leland Stanford Junior University, Department of Veterans Affairs
InventorsLawrence Steinman, Shalina Sheryl Ousman, William H. Robinson
Life of this patent
Estimating the term…
Abstract
The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.
Claims7
A method for inhibiting neuromyelitis optica in a patient, the method comprising:
- administering to said patient a therapeutically effective dose of alpha B-crystallin protein.
Dependencies are inferred from the claim text.